-
Something wrong with this record ?
A systematic evaluation of the cucurbit[7]uril pharmacokinetics and toxicity after a single dose and short-term repeated administration in mice
J. Pejchal, P. Jošt, L. Múčková, R. Andrýs, M. Lísa, J. Zdarova Karasova
Language English Country Germany
Document type Journal Article
Grant support
18-08937S
Grantová Agentura České Republiky
NLK
ProQuest Central
from 2002-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 2000-01-01 to 1 year ago
Health & Medicine (ProQuest)
from 2002-01-01 to 1 year ago
Public Health Database (ProQuest)
from 2002-01-01 to 1 year ago
- MeSH
- Heterocyclic Compounds, 2-Ring * toxicity MeSH
- Imidazolidines * toxicity MeSH
- Macrocyclic Compounds * toxicity MeSH
- Maximum Tolerated Dose MeSH
- Mice MeSH
- Animals MeSH
- Check Tag
- Mice MeSH
- Animals MeSH
- Publication type
- Journal Article MeSH
Cucurbit[n]urils are macrocyclic compounds capable of forming host-guest complexes with different molecules. In this study, we focused on cucurbit[7]uril (CB[7]) safety and pharmacokinetics. We investigated CB[7] cytotocixity in human renal cells ACHN using the xCELLigence system. We also determined maximum tolerated doses (MTD) and no observed adverse effect levels (NOAEL) after intramuscular (i.m.), intraperitoneal (i.p.), and intragastric (i.g.) administration in mice using clinical observation, blood biochemistry, and histopathology. At NOAELs, we studied its pharmacokinetics in plasma and kidneys. Finally, we performed a 7 day repeated-dose toxicity study at 50% of NOAEL after i.p. administration, assaying CB[7] concentration in plasma, brain, kidney, and liver; we also assessed the liver and kidney histopathology. In vitro, CB[7] did not show toxicity up to 0.94 mg/mL. MTDs in vivo were set at 300, 350, and 600 mg/kg, and NOAEL were established at 150, 100, and 300 mg/kg after i.m., i.p., and i.g. administration, respectively. Parenteral administration produced tissue damage mainly to the kidney, while i.g. administration caused only minor liver damage. Parenteral CB[7] administration led to fast elimination from blood, accompanied with kidney accumulation; absorption from the gastrointestinal tract was minimal. Short repeated i.p. administration was well tolerated. After initial CB[7] accumulation in blood and kidney, the concentrations stabilised and decreased during the experiment. Approximately 3.6% of animals showed signs of nephrotoxicity. Although CB[7] appears to be a promising molecule, nephrotoxicity may be the most critical drawback of its parenteral use, because the kidney represents the main organ of its elimination.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc22018507
- 003
- CZ-PrNML
- 005
- 20220804134822.0
- 007
- ta
- 008
- 220720s2022 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00204-022-03249-7 $2 doi
- 035 __
- $a (PubMed)35220471
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Pejchal, Jaroslav $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence in Brno, Hradec Kralove, Czech Republic $1 https://orcid.org/0000000322287922 $7 xx0102560
- 245 12
- $a A systematic evaluation of the cucurbit[7]uril pharmacokinetics and toxicity after a single dose and short-term repeated administration in mice / $c J. Pejchal, P. Jošt, L. Múčková, R. Andrýs, M. Lísa, J. Zdarova Karasova
- 520 9_
- $a Cucurbit[n]urils are macrocyclic compounds capable of forming host-guest complexes with different molecules. In this study, we focused on cucurbit[7]uril (CB[7]) safety and pharmacokinetics. We investigated CB[7] cytotocixity in human renal cells ACHN using the xCELLigence system. We also determined maximum tolerated doses (MTD) and no observed adverse effect levels (NOAEL) after intramuscular (i.m.), intraperitoneal (i.p.), and intragastric (i.g.) administration in mice using clinical observation, blood biochemistry, and histopathology. At NOAELs, we studied its pharmacokinetics in plasma and kidneys. Finally, we performed a 7 day repeated-dose toxicity study at 50% of NOAEL after i.p. administration, assaying CB[7] concentration in plasma, brain, kidney, and liver; we also assessed the liver and kidney histopathology. In vitro, CB[7] did not show toxicity up to 0.94 mg/mL. MTDs in vivo were set at 300, 350, and 600 mg/kg, and NOAEL were established at 150, 100, and 300 mg/kg after i.m., i.p., and i.g. administration, respectively. Parenteral administration produced tissue damage mainly to the kidney, while i.g. administration caused only minor liver damage. Parenteral CB[7] administration led to fast elimination from blood, accompanied with kidney accumulation; absorption from the gastrointestinal tract was minimal. Short repeated i.p. administration was well tolerated. After initial CB[7] accumulation in blood and kidney, the concentrations stabilised and decreased during the experiment. Approximately 3.6% of animals showed signs of nephrotoxicity. Although CB[7] appears to be a promising molecule, nephrotoxicity may be the most critical drawback of its parenteral use, because the kidney represents the main organ of its elimination.
- 650 _2
- $a zvířata $7 D000818
- 650 12
- $a heterocyklické sloučeniny bicyklické $x toxicita $7 D006574
- 650 12
- $a imidazolidiny $x toxicita $7 D048289
- 650 12
- $a makrocyklické sloučeniny $x toxicita $7 D047028
- 650 _2
- $a maximální tolerovaná dávka $7 D020714
- 650 _2
- $a myši $7 D051379
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Jošt, Petr $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence in Brno, Hradec Kralove, Czech Republic
- 700 1_
- $a Múčková, Lubica $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence in Brno, Hradec Kralove, Czech Republic $u Biomedical Research Center, University Hospital, Hradec Kralove, Czech Republic
- 700 1_
- $a Andrýs, Rudolf $u Department of Chemistry, Faculty of Science, University of Hradec Králové, Rokitanského 62, 50003, Hradec Králové, Czech Republic
- 700 1_
- $a Lísa, Miroslav $u Department of Chemistry, Faculty of Science, University of Hradec Králové, Rokitanského 62, 50003, Hradec Králové, Czech Republic
- 700 1_
- $a Zdarova Karasova, Jana $u Department of Toxicology and Military Pharmacy, Faculty of Military Health Sciences, University of Defence in Brno, Hradec Kralove, Czech Republic. zdarova.jana@gmail.com $u Biomedical Research Center, University Hospital, Hradec Kralove, Czech Republic. zdarova.jana@gmail.com
- 773 0_
- $w MED00009265 $t Archives of toxicology $x 1432-0738 $g Roč. 96, č. 5 (2022), s. 1411-1421
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/35220471 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y p $z 0
- 990 __
- $a 20220720 $b ABA008
- 991 __
- $a 20220804134816 $b ABA008
- 999 __
- $a ok $b bmc $g 1822207 $s 1169750
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2022 $b 96 $c 5 $d 1411-1421 $e 20220226 $i 1432-0738 $m Archives of toxicology $n Arch Toxicol $x MED00009265
- GRA __
- $a 18-08937S $p Grantová Agentura České Republiky
- LZP __
- $a Pubmed-20220720